you are here:

Gujarat Themis Biosyn Ltd.

BSE Live

Oct 21, 16:00
515.40 -29.35 (-5.39%)
Volume
AVERAGE VOLUME
5-Day
13,305
10-Day
12,710
30-Day
28,736
21,844
  • Prev. Close

    544.75

  • Open Price

    551.80

  • Bid Price (Qty.)

    515.50 (43)

  • Offer Price (Qty.)

    518.75 (10)

NSE Live

Dec 27, 11:22
7.30 0.60 (8.96%)
Volume
No Data Available
12,785
  • Prev. Close

    6.70

  • Open Price

    -

  • Bid Price (Qty.)

    - (0)

  • Offer Price (Qty.)

    - (0)

Gujarat Themis Biosyn is not listed on NSE

ANNOUNCEMENTS ON Guj Themis

  • Oct 12, 2021 20:00 Source: BSE

    Gujarat Themis Biosyn - Shareholding for the Period Ended September 30, 2021

    Gujarat Themis Biosyn Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here

  • Oct 12, 2021 11:07 Source: BSE

    Gujarat Themis Biosyn - Statement Of Investor Complaints For The Quarter Ended September 2021

    No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
    0440
    Name of the Signatory :- Rahul Soni
    Designation :- Company Secretary and Compliance Officer

  • Oct 12, 2021 10:55 Source: BSE

    Gujarat Themis Biosyn - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited has received below mentioned intimation / request(s) for Loss of Share Certificate(s) / issuance of duplicate share certificate(s) from the following shareholder(s): Sr. No. Name Folio No. Cert. No. Number of Shares Dist. No. From Dist. No. To 1 KALPANA SATISH PARIKH K001528 14762 50 2197201 2197250 2 KALPANA SATISH PARIKH K001528 1958 50 1557001 1557050 3 KALPANA SATISH PARIKH K001528 6397 50 1778951 1779000 We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the Shareholder(s). This may be taken as compliance under the Listing Regulations.

  • Oct 08, 2021 18:56 Source: BSE

    Gujarat Themis Biosyn - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2021 received from Link lntime India Pvt. Ltd., Registrar and Share Transfer Agent of our Company. This is for your information and record.

  • Sep 28, 2021 20:31 Source: BSE

    Gujarat Themis Biosyn - Reporting To SEBI Regarding Acquisition Of Shares By Inter Se Transfer Ref: Regulation 10(7) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 Read With Regulation 30 Of SEBI (LODR) Regulations, 2015.

    In furtherance to intimation under Regulation 10(5) and 10(6) of SEBI (substantial Acquisition of Shares & Take overs) Regulations 2011 ('Takeover Regulations') submitted by Pharmaceutical Business Group (India) Limited ("Acquirer') on 24th July, 2021 and 18th September, 2021 respectively. Acquirer belongs to the Promoter Group of Gujarat Themis Biosyn Limited ("Company') have submitted a report to SEBI on 28th September, 2021, pursuant Regulation 10(7) of Takeover Regulations for acquisition of 38,50,000 (Thirty Eight Lakhs and Fifty Thousand)Equity Shares of the Company by a way of Inter-se transfer in terms of Regulation 10(1)(a)(ii) of Takeover Regulations. Kindly take the same on record and suitably disseminate to all concerned.

  • Sep 28, 2021 12:23 Source: BSE

    Gujarat Themis Biosyn - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Listing Regulations") read with part A of Schedule Ill of the Listing Regulations, we wish to inform that the management of the Company had a one-on-one conference call with Analysts/Investors on Monday, 27th September,2021 the details of the same are given below: Sr. no. Name Venue 1 Kotak PMS Conference Call Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.gtbl.in

  • Sep 23, 2021 15:02 Source: BSE

    Gujarat Themis Biosyn - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    This is to inform with reference to our letter dated September 22, 2021, regarding One-on-One Concall with Analyst / Investor - Kotak PMS, which was scheduled today, has been rescheduled to Monday, 27th September 2021. The details of the same are given below: Sr. no. Name Venue 1 Kotak PMS Conference Call Note: The schedule of the aforesaid meetings is subject to change. The changes may happen due to exigencies on the part of Fund / Broking House / Company. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.gtbl.in This is for your information and record.

  • Sep 22, 2021 19:10 Source: BSE

    Gujarat Themis Biosyn - Announcement Under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Dear Sir / Madam, Subject: Intimation of Investor/Analyst meet Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing Regulations, we wish to inform that the management of the Company will have a one-on-one conference call with Analysts/Investors on Thursday, 23rd September 2021; the details of the same are given below: Sr. no. Name Venue 1 Kotak PMS Conference Call Note: The schedule of the aforesaid meetings is subject to change. The changes may happen due to exigencies on the part of Fund / Broking House / Company. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.gtbl.in This is for your information and record.

  • Sep 20, 2021 10:04 Source: BSE

    Gujarat Themis Biosyn - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

    Gujarat Themis Biosyn Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

  • Sep 20, 2021 8:45 Source: BSE

    Gujarat Themis Biosyn - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pharmaceutical Business Group (India) Ltd

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Aug 12, 2021
Remark : Quarterly Results